Conatus Pharmaceuticals Inc (NASDAQ:CNAT)

5.17
Delayed Data
As of May 26
 -0.19 / -3.54%
Today’s Change
5.13
Today|||52-Week Range
11.74
-26.14%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Revenue and IncomeNet Revenues0.000.000.000.00--
Depreciation And Amortization11.0K9.1K10.4K38.3K
 
 
 
 
 
 
Operating ExpensesGross Income-11.0K-9.1K-10.4K-38.3K
 
 
 
 
 
General Expenses12.4M8.6M11.6M22.2M
 
 
 
 
 
Research And Development9.5M5.5M6.9M14.9M
 
 
 
 
 
Total Operating Expenses12.4M8.6M11.6M22.3M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-12.4M-8.6M-11.6M-22.3M
 
 
 
 
 
Extraordinary Credit454.5K0.000.000.00
 
 
Extraordinary Charge0.00-91.6K-3.5M0.00
 
 
 
Interest Expense On Debt113.8K70.0K462.6K70.0K
 
 
 
 
 
Other Expenses-4.4K1.4K-120.6K-19.3K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-12.0M-8.7M-15.6M-22.3M
 
 
 
 
 
Net Income-12.0M-8.7M-4.6M-22.3M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS9.3M9.3M7.4M15.5M
 
 
 
 
 
Shares To Calculate EPS Diluted9.3M9.3M7.4M15.5M
 
 
 
 
 
 
Earnings Per ShareEPS-$11.86-$0.94-$0.63-$1.44
 
 
 
 
 
EPS Diluted-$1.30-$0.95-$0.63-$1.44
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account